Legal & General Group Plc - PROQR THRAPEUTICS N V ownership

PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 51 filers reported holding PROQR THRAPEUTICS N V in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Legal & General Group Plc ownership history of PROQR THRAPEUTICS N V
ValueSharesWeighting
Q3 2019$323,000
-47.0%
55,917
-16.5%
0.00%
Q2 2019$610,000
-34.3%
66,9420.0%0.00%
-100.0%
Q1 2019$928,000
-12.2%
66,9420.0%0.00%0.0%
Q4 2018$1,057,00066,9420.00%
Other shareholders
PROQR THRAPEUTICS N V shareholders Q3 2019
NameSharesValueWeighting ↓
M28 Capital Management LP 1,910,600$3,095,1724.09%
Privium Fund Management B.V. 5,344,446$8,658,0031.82%
DAFNA Capital Management LLC 940,582$1,523,7430.42%
Opaleye Management Inc. 653,000$1,057,8600.25%
Ikarian Capital, LLC 472,625$765,6530.12%
EcoR1 Capital, LLC 2,980,016$4,827,6260.12%
Monaco Asset Management SAM 237,517$384,7780.11%
FRANKLIN STREET ADVISORS INC /NC 150,000$2430.02%
ADAGE CAPITAL PARTNERS GP, L.L.C. 3,625,467$5,873,2570.01%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 189,328$306,7110.01%
View complete list of PROQR THRAPEUTICS N V shareholders